TSRI researchers win $2.8 million to unravel cell basics linked to disease

December 02, 2015

LA JOLLA, CA - Dec. 2, 2015 -- Mutations in a meshwork of proteins at the outer edge of the cell nucleus, called the nuclear lamina, have been linked to many diseases -- from muscular dystrophies and heart disorders to type 2 diabetes and premature aging.

Now, scientists at The Scripps Research Institute (TSRI) are on a mission to explore the nuclear lamina in new ways with the support of a grant of more than $2.8 million from the National Institutes of Health (NIH) Common Fund.

"We have to understand, in detail, the composition of the lamina and its underlying protein interaction network, so we can develop therapies for these diseases," said TSRI Professor Larry Gerace, who will lead the new five-year project, in which Gerace's group will work closely with the laboratory of TSRI Professor John R. Yates. The project is part of the NIH Common Fund's 4D Nucleome program, which aims to shed light on how cells organize their genetic material and how this organization changes in different cell types and affects gene expression over time.

The nuclear lamina (Latin for 'thin sheet of material') is a network of fibrous proteins sandwiched between the membrane that forms the cell's nuclear boundary and the thread-like, DNA-containing chromosomes that occupy the interior of the nucleus. Proteins associated with chromosomes attach to the nuclear lamina, ensuring the chromosomes are placed in the right order.

For many years, scientists believed the nuclear lamina was involved strictly in nuclear organization, but research in the 1990s revealed a connection to disease and suggested more extensive functions. Mutations in the nuclear lamina's "lamin" proteins and the membrane proteins attached to nuclear lamins can somehow alter the functioning of specific cell types such as muscle and fat or the ability of stem cells to form these differentiated cells.

"We still don't understand the most fundamental molecular basis for how these mutations lead to disease," said Gerace.

With the new grant, the researchers hope to solve that mystery.

Gerace and his colleagues will isolate the nuclear lamina and associated chromatin from muscle and fat cells, as well as precursor stem cells, and with Yates lab, analyze how the nuclear lamins, nuclear membrane proteins and their cellular neighbors interact to create the nuclear lamina's meshwork and to organize and regulate chromosomes. The researchers will rely on new technologies, developed in the Yates lab, to capture high-resolution data on protein interactions.
The number of the grant is 1U01DA040709.

Scripps Research Institute

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.